nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.182	0.611	CbGbCtD
Perhexiline—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.116	0.389	CbGbCtD
Perhexiline—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.05	0.138	CcSEcCtD
Perhexiline—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0487	0.135	CcSEcCtD
Perhexiline—CPT2—nephron tubule—focal segmental glomerulosclerosis	0.0398	0.223	CbGeAlD
Perhexiline—CPT1A—kidney—focal segmental glomerulosclerosis	0.0369	0.206	CbGeAlD
Perhexiline—CPT2—kidney—focal segmental glomerulosclerosis	0.035	0.196	CbGeAlD
Perhexiline—CPT2—cortex of kidney—focal segmental glomerulosclerosis	0.0341	0.191	CbGeAlD
Perhexiline—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.0763	CcSEcCtD
Perhexiline—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.0258	0.0713	CcSEcCtD
Perhexiline—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0242	0.0669	CcSEcCtD
Perhexiline—CPT2—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.023	0.143	CbGpPWpGaD
Perhexiline—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0189	0.0521	CcSEcCtD
Perhexiline—CPT1A—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.016	0.0993	CbGpPWpGaD
Perhexiline—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0438	CcSEcCtD
Perhexiline—CPT2—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.0141	0.0874	CbGpPWpGaD
Perhexiline—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0326	CcSEcCtD
Perhexiline—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.0104	0.0579	CbGeAlD
Perhexiline—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0281	CcSEcCtD
Perhexiline—CPT1A—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.00974	0.0606	CbGpPWpGaD
Perhexiline—CYP2B6—kidney—focal segmental glomerulosclerosis	0.0091	0.0509	CbGeAlD
Perhexiline—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00902	0.0249	CcSEcCtD
Perhexiline—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.024	CcSEcCtD
Perhexiline—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.022	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00793	0.0493	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00776	0.0483	CbGpPWpGaD
Perhexiline—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.0074	0.0204	CcSEcCtD
Perhexiline—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00687	0.0385	CbGeAlD
Perhexiline—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00681	0.0188	CcSEcCtD
Perhexiline—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00676	0.0378	CbGeAlD
Perhexiline—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.0186	CcSEcCtD
Perhexiline—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00651	0.018	CcSEcCtD
Perhexiline—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00602	0.0166	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.0055	0.0342	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.0151	CcSEcCtD
Perhexiline—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0054	0.0149	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00538	0.0334	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00535	0.0332	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.0052	0.0324	CbGpPWpGaD
Perhexiline—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.0141	CcSEcCtD
Perhexiline—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.014	CcSEcCtD
Perhexiline—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.0136	CcSEcCtD
Perhexiline—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0135	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.0047	0.0292	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0128	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.0046	0.0286	CbGpPWpGaD
Perhexiline—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0124	CcSEcCtD
Perhexiline—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.0124	CcSEcCtD
Perhexiline—CPT1A—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.00436	0.0271	CbGpPWpGaD
Perhexiline—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0112	CcSEcCtD
Perhexiline—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.0103	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00371	0.023	CbGpPWpGaD
Perhexiline—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00994	CcSEcCtD
Perhexiline—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00986	CcSEcCtD
Perhexiline—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00985	CcSEcCtD
Perhexiline—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.0098	CcSEcCtD
Perhexiline—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00929	CcSEcCtD
Perhexiline—CPT1A—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00326	0.0203	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00319	0.0198	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00317	0.0197	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00313	0.0194	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00242	0.015	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.0022	0.0137	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00213	0.0132	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00188	0.0117	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00184	0.0114	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00168	0.0104	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00155	0.00962	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00148	0.00918	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00148	0.00918	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00126	0.00785	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00108	0.0067	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00102	0.00636	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000969	0.00603	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000948	0.0059	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000875	0.00544	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000874	0.00543	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000746	0.00464	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000672	0.00418	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000657	0.00409	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000657	0.00409	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000606	0.00377	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000562	0.0035	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000456	0.00283	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000431	0.00268	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AGT—focal segmental glomerulosclerosis	0.00039	0.00242	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000299	0.00186	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000177	0.0011	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000156	0.000967	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000143	0.000891	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000123	0.000764	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000108	0.000672	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000108	0.00067	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.96e-05	0.000619	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	9.22e-05	0.000574	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	8.03e-05	0.000499	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	7.49e-05	0.000466	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	7.08e-05	0.00044	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	7.07e-05	0.00044	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.51e-05	0.000405	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	6.41e-05	0.000399	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	4.92e-05	0.000306	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	4.9e-05	0.000305	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.19e-05	0.000261	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.22e-05	0.0002	CbGpPWpGaD
